Shire plc Press Releases

SHPG 
$219.26
*  
2.91
1.31%
Get SHPG Alerts
*Delayed - data as of Jan. 30, 2015  -  Find a broker to begin trading SHPG now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Vyvanse® (lisdexamfetamine dimesylate) Capsules (CII) Becomes First and Only Treatment Approved by the FDA for Adults with Moderate to Severe Binge Eating Disorder
1/30/2015 9:24:00 PM - PR Newswire


U.S. Supreme Court Grants Shire Petition
1/27/2015 5:00:00 PM - PR Newswire
▼-0.79 % Price Change since this news event. The Volume Ratio is 0.68.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


NPS PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of NPS Pharmaceuticals, Inc. (NPSP) Over the Proposed Sale of the Company to Shire PLC
1/27/2015 2:37:00 PM - Business Wire


Shire's Investigational SHP609, idursulfase-IT, Receives FDA Fast Track Designation for the Treatment of Neurocognitive Decline Associated with Hunter Syndrome
1/26/2015 2:00:00 AM - PR Newswire
▲3.33 % Price Change since this news event. The Volume Ratio is 2.2.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Shire Comments on Press Release from NPS Pharma Regarding FDA Approval of NATPARA® (parathyroid hormone)
1/23/2015 8:25:00 PM - PR Newswire
▲3.33 % Price Change since this news event. The Volume Ratio is 2.2.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Positive Response From European Decentralised Procedure for Elvanse Adult® ? (lisdexamfetamine dimesylate) in Adults With ADHD
1/22/2015 2:05:00 AM - PR Newswire
▲1.05 % Price Change since this news event. The Volume Ratio is 1.19.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Shire Added to Global 100 Sustainability Index
1/21/2015 4:34:00 PM - PR Newswire
▲1.05 % Price Change since this news event. The Volume Ratio is 1.23.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


NPS PHARMACEUTICALS, INC. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of NPS Pharmaceuticals, Inc. Over the Proposed Sale of the Company to Shire Plc - NPSP
1/16/2015 8:00:00 PM - PR Newswire


NPS PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
1/16/2015 5:40:00 PM - Business Wire


Harwood Feffer LLP Announces Investigation of NPS Pharmaceuticals, Inc.
1/12/2015 8:00:00 PM - PR Newswire


NPS PHARMACEUTICALS, INC. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of NPS Pharmaceuticals, Inc. Over the Proposed Sale of the Company to Shire Plc
1/12/2015 7:00:00 PM - Business Wire


Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of NPS Pharmaceuticals, Inc. Stockholders
1/12/2015 6:35:00 PM - Business Wire


NPS Pharmaceuticals, Inc. Acquisition By Shire Plc May Not Be In The Best Interests Of NPSP Shareholders
1/12/2015 5:08:00 PM - PR Newswire


NPS PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
1/12/2015 10:50:00 AM - PR Newswire


Oxis Biotech Executes Worldwide Exclusive Patent Licensing "P62 Chemical Agents and Multiple Myeloma Therapeutics" with Dr. Xiang-Qun (Sean) Xie, Professor of Pharmaceutical Sciences at University of Pittsburgh
1/12/2015 7:30:00 AM - PR Newswire


PLShire to Acquire NPS Pharma as Further Step in Building a Leading Biotech
1/11/2015 11:01:00 AM - PR Newswire
▲0.81 % Price Change since this news event. The Volume Ratio is 1.73.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


BBCN Bancorp to Announce Fourth Quarter 2014 Financial Results on Monday, January 26, 2015
1/8/2015 5:07:00 PM - GlobeNewswire


Shire to Present at 33rd Annual J.P. Morgan Healthcare Conference
1/6/2015 9:00:00 AM - PR Newswire
▲5.32 % Price Change since this news event. The Volume Ratio is 1.3.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Shire R&D Day Profiles Innovative Pipeline Expected to Contribute $3 Billion in Product Sales by 2020
12/10/2014 7:00:00 AM - PR Newswire
▲5.60 % Price Change since this news event. The Volume Ratio is 3.38.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Cystic Fibrosis Foundation Therapeutics Announces $15 Million Research Collaboration with Shire for Development of Novel CF Treatment
12/10/2014 6:55:00 AM - PR Newswire


Actavis Launches Generic Version of Intuniv®
12/1/2014 4:05:00 PM - PR Newswire


Shire to Highlight Pipeline Progress and Breadth of Innovative Portfolio in R&D Day
12/1/2014 7:30:00 AM - PR Newswire
▲1.84 % Price Change since this news event. The Volume Ratio is 1.69.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


FTI Consulting Projects U.S. Online Retail Sales Will Grow to $512 Billion by 2020
12/1/2014 7:30:00 AM - PR Newswire


Agilis Biotherapeutics Names Former Shire Executive Dr. Gregory Robinson as Chief Scientific Officer
11/24/2014 9:00:00 AM - Business Wire


Event Cardio Group Acquires Worldwide Rights to Now Cardio(TM), Advanced Cardiac Monitoring Device
11/19/2014 10:30:00 AM - Market Wire